WHO. Considerations for use of avian influenza A(H5) vaccines during the interpandemic and emergence periods: report of a WHO virtual scientific consultation, September 2024. WHO
WHO conducted a virtual scientific expert consultation on A(H5) vaccines and vaccination. This report provides an overview of the landscape of A(H5) vaccines and summarizes options for Member States´ potential use of A(H5) vaccination during the interpandemic and emergence periods.
See Also:
Latest articles in those days:
- Avian Influenza Weekly Update # 1048: 6 June 2026 12 hours ago
- Comparative immunogenicity and cross-protection of wild-type and reverse genetics H5N8 (clade 2.3.4.4b) oil-adjuvanted vaccines against circulating H5N1 avian influenza viruses from clades 2.3.4.4b an 19 hours ago
- Compartmentalized cytokine networks and systemic immune remodelling in bovine mammary H5N1 infection 19 hours ago
- Public-private partnership framework for highly pathogenic avian influenza surveillance: A Korean model 1 days ago
- Rab11B is required for binding and entry of recent H3N2, but not H1N1, influenza A isolates 2 days ago
[Go Top] [Close Window]
